Research / NVDA / Fundamental state Inspectable configuration
State dimensions Filing 0001045810-26-000021 General Corporate
Debt relative to revenue 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
3.92% · OPTIONAL · VALID
Capex intensity 42th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.80% · OPTIONAL · VALID
Operating cash generation 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
47.57% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
65.47% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
9.91% · OPTIONAL · VALID
Gross margin 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
71.07% · CORE · VALID
Operating margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
60.38% · CORE · VALID
R&D intensity 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
8.57% · OPTIONAL · VALID
SBC intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.96% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Oct 31, 2021 0/9 normalized Level 3 Jan 30, 2022 0/8 normalized Level 3 May 1, 2022 0/8 normalized Level 3 Jul 31, 2022 6/8 normalized Level 3 Oct 30, 2022 7/8 normalized Level 3 Jan 29, 2023 7/8 normalized Level 3 Apr 30, 2023 7/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Oct 29, 2023 8/8 normalized Level 3 Jan 28, 2024 8/9 normalized Level 3 Apr 28, 2024 8/9 normalized Level 3 Jul 28, 2024 8/9 normalized Level 3 Oct 27, 2024 8/9 normalized Level 3 Jan 26, 2025 9/9 normalized Level 3 Apr 27, 2025 9/9 normalized Level 3 Jul 27, 2025 9/9 normalized Level 3 Oct 26, 2025 9/9 normalized Level 3 Jan 25, 2026 9/9 normalized Level 3 Apr 26, 2026 9/9 normalized Level 3 Jul 26, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 14.85%
Current 3.92%
Delta -10.93% Capex Intensity Decreased
Previous 2.87%
Current 2.80%
Delta -0.07% Cash Generation Increased
Previous 41.66%
Current 47.57%
Delta 5.90% Growth Increased
Previous 62.49%
Current 65.47%
Delta 2.98% Inventory Pressure Decreased
Previous 34.71%
Current 9.91%
Delta -24.79% Margin Decreased
Previous 73.41%
Current 71.07%
Delta -2.34% Profitability Decreased
Previous 63.17%
Current 60.38%
Delta -2.79% R And D Intensity Increased
Previous 8.25%
Current 8.57%
Delta 0.31% Sbc Intensity Increased
Previous 2.90%
Current 2.96%
Delta 0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.